Jinesh P. Mehta
Expertise in
20
conditions

Dr. Jinesh P. Mehta

Pulmonary Medicine | Intensive Care Medicine
2950 Cleveland Clinic Boulevard, 
Weston, FL 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
20
conditions
2950 Cleveland Clinic Boulevard, 
Weston, FL 

Overview

Jinesh Mehta is a Pulmonary Medicine specialist and an Intensive Care Medicine provider practicing medicine in Weston, Florida.

Dr. Mehta is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Interstitial Lung Disease, Acute Interstitial Pneumonia, Emphysema, and Advanced Bronchoscopy.

Dr. Mehta is board certified in American Board Of Internal Medicine, 2008. He is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 7 clinical trials. Dr. Mehta is currently accepting new patients.

Specialties

Pulmonary Medicine
Intensive Care Medicine

Licenses

Internal Medicine in FL

Board Certifications

American Board Of Internal Medicine, 2008

Fellowships

University of Louisville School of Medicine

Hospital Affiliations

Boca Raton Regional Hospital
Cleveland Clinic Martin North Hospital
Cleveland Clinic Hospital

Languages Spoken

English
Gujarati 
Hindi
Marathi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
SummaCare
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 30 Less Insurance Carriers -

Locations

Egil and Pauline Braathen Center/Maroone Cancer Center
2950 Cleveland Clinic Boulevard, Weston, FL 33331

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

19 Total Publications

CLO26-097: Robotic-Assisted Bronchoscopy (RAB) Compared to CT-Guided Transthoracic Biopsy (CTTB) in the Diagnosis of Lung Malignancy.
CLO26-097: Robotic-Assisted Bronchoscopy (RAB) Compared to CT-Guided Transthoracic Biopsy (CTTB) in the Diagnosis of Lung Malignancy.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
Similar Doctors
Expertise in
18
conditions
Dr. Farzad F. Rahaghi
Pulmonary Medicine
Expertise in
18
conditions
Dr. Farzad F. Rahaghi
Pulmonary Medicine
Referral may be required

Office

2950 Cleveland Clinic Blvd Fl 3, 
Weston, FL 
 (1.6 miles away)
954-659-5450
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Farzad Rahaghi is a Pulmonary Medicine provider practicing medicine in Weston, Florida. Dr. Rahaghi is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Alpha-1 Antitrypsin Deficiency (AATD), Interstitial Lung Disease, Lung Transplant, and Vertebroplasty. Dr. Rahaghi is currently accepting new patients.

Expertise in
17
conditions
Dr. Roger A. Alvarez
Pulmonary Medicine | Intensive Care Medicine
Expertise in
17
conditions
Dr. Roger A. Alvarez
Pulmonary Medicine | Intensive Care Medicine
Referral may be required
Before you request

Egil And Pauline Braathen Center/Maroone Cancer Center

2950 Cleveland Clinic Boulevard, 
Weston, FL 
 (0.1 miles away)
877-463-2010
Experience:
17+ years
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Roger Alvarez is a Pulmonary Medicine specialist and an Intensive Care Medicine provider practicing medicine in Weston, Florida. He has been practicing medicine for over 17 years. Dr. Alvarez is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Thrombectomy. Dr. Alvarez is board certified in American Board Of Internal Medicine, 2017. Dr. Alvarez is currently accepting new patients.

Expertise in
24
conditions
Dr. David A. Zisman
Pulmonary Medicine
Expertise in
24
conditions
Dr. David A. Zisman
Pulmonary Medicine
Referral may be required
Before you request

Weston Emergency Physicians LLC

3100 Weston Rd, 
Weston, FL 
 (0.1 miles away)
877-463-2010
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

David Zisman is a Pulmonary Medicine provider practicing medicine in Weston, Florida. Dr. Zisman is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Pneumonia, and Lung Transplant. Dr. Zisman is currently accepting new patients.

Frequently Asked Questions about Dr. Jinesh P. Mehta

How do I make an appointment with Dr. Jinesh P. Mehta?

You can book an appointment with Dr. Jinesh P. Mehta by calling their office at 877-463-2010. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jinesh P. Mehta a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jinesh P. Mehta is classified as an Distinguished expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jinesh P. Mehta specialize in?

While Dr. Jinesh P. Mehta is a Pulmonary Medicine, they have specific expertise in Pulmonary Hypertension, Interstitial Lung Disease, and Acute Interstitial Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Jinesh P. Mehta participate in research or clinical trials?

Yes. Dr. Jinesh P. Mehta has published 19 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Jinesh P. Mehta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jinesh P. Mehta accept my insurance?

Dr. Jinesh P. Mehta accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 877-463-2010 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mehta's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 12 Advanced Conditions
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile